...
首页> 外文期刊>The Internet Journal of Anesthesiology >Use Of Low-Dose Suxamethonium To Facilitate Laryngeal Mask Insertion Under Etomidate Anaesthesia
【24h】

Use Of Low-Dose Suxamethonium To Facilitate Laryngeal Mask Insertion Under Etomidate Anaesthesia

机译:依托咪酯麻醉下使用小剂量地塞米松来促进喉罩插入

获取原文
           

摘要

Despite the popularity of laryngeal masks (LMA) for airway maintenance during general anaesthesia, there is still no optimal induction technique that guarantees good insertion conditions whilst maintaining cardiovascular stability and rapid onset of respiration. The most popular induction agent for LMA insertion continues to be propofol as this agent best obtunds oropharyngeal reflexes1,2. Studies show an incidence of poor insertion conditions ranging from 38 to 60%3,4,5 with standard induction doses (2-3mg kg-1) of propofol. However, its use in doses which allow adequate jaw relaxation and prevent patient reaction to LMA insertion1,5 i.e., movement & laryngospasm commonly results in hypotension 6,7,8,9,10,11 and prolonged apnoea12. Although probably inconsequential in a fit patient, these side effects are undesirable in the elderly or those with cardiovascular disease. Introduction There have been numerous papers that looked into co-induction techniques combining a lower dose of propofol or thiopentone with other agents, including benzodiazepines13,14,15,16, rapidly acting opiates3,16 neuromuscular blocking agents4,17,18,19 and topical20 or intravenous5 local anaesthetic agents. Etomidate is known to have greater cardiovascular stability than the other intravenous induction agents, even in patients with cardiovascular risk factors 11,12,21,23. In this study, we propose to use the combination of etomidate 0.3mg kg -1 with various low doses of suxamethonium so as to obtain good LMA insertion conditions whilst maintaining cardiovascular stability. Methods With Institutional Ethics Committee approval, 60 ASA I & II patients were randomly allocated into 3 groups of 20 patients. We excluded all patients suffering from cardiovascular disorders or taking anti-hypertensive or cardiac drugs that could interfere with normal cardiovascular physiology. The patients age range was 17 to 59 years. All subjects presented to the Singapore General Hospital for surgery under general anaesthesia with spontaneous ventilation through a laryngeal mask airway. Informed consent was obtained from all patients pre-operatively.All patients were unpremedicated. Non-invasive blood pressure (NIBP), electrocardiogram (ECG) and pulse oximetry were monitored using a Hewlett Packard GMX modular system and intravenous access secured prior to pre-oxygenation. Induction of anaesthesia was performed with a rapid bolus of etomidate 0.3mg kg-1. This was followed immediately by the administration of normal saline in group A, suxamethonium 0.25mg kg-1 in group B and suxamethonium 0.5mg kg-1 in group C. The study drug was made up to 2ml with normal saline to ensure that the anaesthetist inserting the laryngeal mask was blinded to the treatment given. The laryngeal mask was then inserted 60 seconds after the administration of the drugs in the manner described in the Intravent manual. If jaw relaxation was found to be inadequate to permit LMA insertion, boluses of propofol 50mg were given until adequate relaxation occurred. The position of the LMA was verified by capnography, chest movement and the absence of gas leak around the cuff.Heart rate (HR) and mean arterial blood pressure (MAP) readings were taken pre-induction, 30 seconds post-induction, and 30 seconds post-LMA insertion. The apnoea time was taken from time of insertion of LMA to resumption of respiration. Inhalational anaesthetic agents were not delivered to the patients until after the resumption of respiration. Ventilation was not assisted unless the patient's oxygen saturation fell below 95%. In that instance, the apnoea time was abandoned. The number of attempts taken to insert the laryngeal mask was noted together with degree of jaw relaxation and overall insertion conditions. The reaction from the patient was also graded.Jaw relaxation was graded as 1=good, 2=incomplete or 3=poor according to the classification by Young, Clark and Dundee21. Overall insertion conditions were graded in a system modified fr
机译:尽管在全身麻醉期间喉罩(LMA)广泛用于气道维护,但仍没有最佳的诱导技术来保证良好的插入条件,同时保持心血管的稳定性和呼吸的快速发作。 LMA插入最流行的诱导剂仍然是丙泊酚,因为该剂最能抵抗口咽反射1,2。研究表明,使用异丙酚标准诱导剂量(2-3mg kg-1)时,不良的插入条件发生率为38%至60%3,4,5。但是,其使用剂量可使颌部充分放松并防止患者对LMA的插入产生反应1,5,即运动和喉痉挛通常会导致低血压6,7,8,9,10,11和延长的呼吸暂停12。尽管在合适的患者中可能无关紧要,但这些副作用在老年人或患有心血管疾病的患者中是不希望的。引言有许多论文探讨了共诱导技术,将低剂量的异丙酚或硫代戊酮与其他药物联合使用,包括苯二氮卓类药物13、14、15、16,快速作用的鸦片剂3、16神经肌肉阻滞剂4、17、18、19和局部用药20或静脉注射5种局部麻醉剂。依托咪酯已知具有比其他静脉内诱导剂更高的心血管稳定性,即使在具有心血管危险因素的患者中也是如此11、12、21、23。在这项研究中,我们建议将依托咪酯0.3mg kg -1与各种低剂量的丁二铵联合使用,以在维持心血管稳定性的同时获得良好的LMA插入条件。方法60例经机构伦理委员会批准,将ASA I和II型患者随机分为3组,每组20名患者。我们排除了所有患有心血管疾病或服用可能干扰正常心血管生理的抗高血压药或强心药的患者。患者年龄范围为17至59岁。所有受试者均在全麻下通过喉罩气道自发通气,被送往新加坡综合医院进行手术。术前所有患者均获得知情同意。所有患者均未接受药物治疗。使用Hewlett Packard GMX模块化系统监测无创血压(NIBP),心电图(ECG)和脉搏血氧饱和度,并在预充氧前确保静脉通路。用快速推注依托咪酯0.3mg kg-1进行麻醉诱导。随后立即给予A组生理盐水,B组suxamethonium 0.25mg kg-1和C组suxamethonium 0.5mg kg-1。将研究药物用生理盐水补足2ml,以确保麻醉师插入喉罩对给定的治疗不了解。然后在药物施用后60秒以Intravent手册中描述的方式插入喉罩。如果发现颌骨松弛不足以允许LMA插入,则给予异丙酚50mg推注,直到发生充分的松弛。 LMA的位置通过二氧化碳描记法,胸部运动和袖带周围无气体泄漏得到了验证。心率(HR)和平均动脉血压(MAP)读数在诱导前,诱导后30秒和30 LMA插入后的秒数。呼吸暂停时间从插入LMA到恢复呼吸为止。直到呼吸恢复后才向患者提供吸入麻醉剂。除非患者的氧饱和度降至95%以下,否则不得进行通气。在这种情况下,呼吸暂停时间被放弃了。记录了插入喉罩的尝试次数,颌骨松弛程度和整体插入情况。患者的反应也被分级,根据Young,Clark和Dundee21的分类,下颌放松的等级分为1 =好,2 =不完全或3 =差。总体插入条件在系统修改后的fr中分级

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号